Thus, METTL3 depletion accompanied broader modulations in the AS landscape of breast cancer cells lines compared to the non-tumorigenic MCF10-A, suggesting a critical role of METTL3 in regulating tumor-associated AS switches (Supplementary Fig. 3C). This evidence concerns the gene METTL3 and breast cancer.